SORRENTINO, SABATO
 Distribuzione geografica
Continente #
NA - Nord America 2.059
AS - Asia 1.536
EU - Europa 648
SA - Sud America 217
Continente sconosciuto - Info sul continente non disponibili 197
AF - Africa 37
OC - Oceania 1
Totale 4.695
Nazione #
US - Stati Uniti d'America 1.980
SG - Singapore 621
CN - Cina 341
IT - Italia 322
BD - Bangladesh 192
BR - Brasile 173
IN - India 117
VN - Vietnam 109
DE - Germania 68
HK - Hong Kong 59
NL - Olanda 49
GB - Regno Unito 48
SE - Svezia 44
CA - Canada 37
FI - Finlandia 36
MX - Messico 25
IQ - Iraq 18
FR - Francia 15
ZA - Sudafrica 14
AR - Argentina 12
AT - Austria 9
CO - Colombia 9
ID - Indonesia 9
PK - Pakistan 9
PL - Polonia 9
EC - Ecuador 8
JP - Giappone 8
ES - Italia 7
TR - Turchia 7
SA - Arabia Saudita 6
UZ - Uzbekistan 6
CZ - Repubblica Ceca 5
JO - Giordania 5
MY - Malesia 5
RO - Romania 5
RU - Federazione Russa 5
UA - Ucraina 5
AE - Emirati Arabi Uniti 4
KE - Kenya 4
PH - Filippine 4
PY - Paraguay 4
SC - Seychelles 4
UY - Uruguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
BE - Belgio 3
BH - Bahrain 3
CR - Costa Rica 3
DZ - Algeria 3
ET - Etiopia 3
LT - Lituania 3
PT - Portogallo 3
TN - Tunisia 3
CH - Svizzera 2
CL - Cile 2
DK - Danimarca 2
EG - Egitto 2
HN - Honduras 2
IE - Irlanda 2
MA - Marocco 2
NO - Norvegia 2
PA - Panama 2
PR - Porto Rico 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AW - Aruba 1
BB - Barbados 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
GR - Grecia 1
HT - Haiti 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
MN - Mongolia 1
NP - Nepal 1
NR - Nauru 1
OM - Oman 1
PE - Perù 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
Totale 4.498
Città #
San Jose 444
Singapore 265
Ashburn 235
Santa Clara 134
Chandler 108
Bengaluru 96
Hefei 94
Dallas 91
Council Bluffs 81
Beijing 72
Milan 62
Hong Kong 58
Phoenix 53
Munich 44
New York 44
Los Angeles 43
Chicago 40
Ho Chi Minh City 37
Lawrence 37
Princeton 37
London 27
Rome 26
Helsinki 22
Hanoi 21
São Paulo 21
Wilmington 21
Catanzaro 19
Amsterdam 17
Mexico City 14
Turku 14
Buffalo 13
Naples 13
Brooklyn 11
Assago 10
Atlanta 10
Boardman 10
Chennai 10
Ottawa 10
Haiphong 9
Johannesburg 9
San Francisco 9
Shanghai 9
Baghdad 8
Des Moines 8
Orem 8
Stockholm 8
Brescia 7
Bari 6
Bologna 6
Charlotte 6
Montreal 6
Redmond 6
Tashkent 6
Tokyo 6
Warsaw 6
Denver 5
Hanover 5
Jakarta 5
Manchester 5
Miami 5
Nuremberg 5
Palermo 5
Seattle 5
Abbeville 4
Augusta 4
Brasília 4
Cape Town 4
Da Nang 4
Erbil 4
Huntington 4
Las Vegas 4
Macaé 4
Madison 4
Nairobi 4
Newark 4
Olomouc 4
Orangeburg 4
Rio de Janeiro 4
Sorocaba 4
Toronto 4
Verona 4
Addis Ababa 3
Amman 3
Ankara 3
Baku 3
Biên Hòa 3
Boston 3
Campinas 3
Chieti 3
Cosenza 3
Ferrara 3
Guangzhou 3
Houston 3
Jeddah 3
Jersey City 3
Kuala Lumpur 3
Lahore 3
Montevideo 3
Ninh Bình 3
Perugia 3
Totale 2.656
Nome #
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention 138
Risk of Bleeding in Elderly Patients Undergoing Transcatheter Aortic Valve Implantation or Surgical Aortic Valve Replacement 97
Empagliflozin prevents doxorubicin-induced myocardial dysfunction 91
Effect of valve design and anticoagulation strategy on 30‐day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial 85
Hand Laser Perfusion Imaging to Assess Radial Artery Patency: A Pilot Study. 75
Early hemodynamic impact of SGLT2 inhibitors in overweight cardiometabolic heart failure: beyond fluid offloading to vascular adaptation– a preliminary report 72
B-Type Natriuretic Peptide as Biomarker of COVID-19 Disease Severity-A Meta-Analysis 72
Multichannel Electrocardiograms Obtained by a Smartwatch for the Diagnosis of ST-Segment Changes 70
Hindlimb Ischemia Impairs Endothelial Recovery and Increases Neointimal Proliferation in the Carotid Artery. 68
Indirect Comparison of the Efficacy and Safety of Alirocumab and Evolocumab: A Systematic Review and Network Meta-Analysis 67
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials 64
Incidence, Predictors, and Prognostic Impact of Neurologic Events After TAVR According to VARC-3 Criteria 63
Down-Regulation of miR-23/27/24 Clusters by TGF-beta 1 Signalling Induces Phenotypic Switching of Vascular Smooth Muscle Cells in vitro and in Response to Vascular Injury in vivo. 62
Mir-16 Modulates Endothelial Dysfunction After Balloon Injury in a Rat Model of Chronic Peripheral Ischemia. 61
Dual anti-thrombotic treatment with direct anticoagulants improves clinical outcomes in patients with Atrial Fibrillation with ACS or undergoing PCI. A systematic review and meta-analysis 61
The duration of balloon inflation affects the luminal diameter of coronary segments after Bioresorbable Vascular Scaffolds deployment 60
Flow-Responsive Noncoding RNAs in the Vascular System: Basic Mechanisms for the Clinician 58
Mechanical heart valves between myths and new evidence: a systematic review and meta-analysis 57
Incidence and outcomes of transient new-onset atrial fibrillation complicating acute coronary syndromes: results from a systematic review and meta-analysis 56
The Role of Mir-16 on Endothelial Dysfunction in Rat with Atherosclerotic Diet with a Chronic Model of Femoral Artery Occlusion and Carotid Balloon Injury. 55
Predictors of outcomes in patients with mitral regurgitation undergoing percutaneous valve repair 55
Corrigendum to “miR-125a-5p Modulates Phenotypic Switch of Vascular Smooth Muscle Cells by Targeting ETS-1” (J. Mol. Biol. Jun 16 2017; 429(12):1817–1828) (S002228361730222X) (10.1016/j.jmb.2017.05.008) 55
Percutaneous closure versus medical treatment in stroke patients with patent foramen ovale. A Systematic review and meta-analysis. 53
Instantaneous wave-Free Ratio (iFR) and Gradient (iFG): new promising adenosine-independent alternative to fractional flow reserve. Preliminary results from the FORECAST Study. 53
Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement 53
Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients 53
MicroRNA-1 Downregulation Increases Connexin 43 Displacement and Induces Ventricular Tachyarrhythmias in Rodent Hypertrophic Hearts. 52
The instantaneous wave-Free Ratio (iFR) for evaluation of non culprit lesions in patients with Acute Coronary Syndrome and multivessel disease. 52
Delayed sudden radial artery rupture after left transradial coronary catheterization: a case report. 51
Strategies to Minimize Access Site-related Complications in Patients Undergoing Transfemoral Artery Procedures with Large-bore Devices 50
Cellular and Molecular Mechanisms Underlying Tricuspid Valve Development and Disease 50
New Antithrombotic Strategies and Coronary Stent Technologies for Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention 50
Calculated Serum Osmolality, Acute Kidney Injury, and Relationship to Mortality after Percutaneous Coronary Intervention 49
Acute expansion of nitinol-based self-expandable device in patients undergoing transfemoral aortic valve implantation 49
Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention 49
The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO‐3 trial 49
Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 48
Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trials 47
Single Versus Dual Antiplatelet Therapy Following TAVR: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 47
The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function 46
Direct Oral Anticoagulants in Patients With Active Cancer 46
Non-invasive myocardial work is reduced during transient acute coronary occlusion 45
Prediction of Significant Coronary Artery Disease Through Advanced Echocardiography: Role of Non-invasive Myocardial Work 45
Down-regulation of miR-23b induces phenotypic switching of vascular smooth muscle cells in vitro and in vivo 45
[Debate on dual pathway inhibition: Antiplatelet and anticoagulant therapies in patients undergoing percutaneous coronary intervention at high risk for recurrent ischemic events. Focus on anticoagulation-based strategies] 44
Non-Invasive Myocardial Work in Patients with Severe Aortic Stenosis 44
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention 42
Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study 41
Small‐vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus‐eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post‐Approval studies 41
White blood cell count and clinical outcomes after left main coronary artery revascularization: insights from the EXCEL trial 41
Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation 40
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk 40
Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor. 40
Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients for the Treatment of Severe Aortic Stenosis 40
Edwards SAPIEN Versus Medtronic Aortic Bioprosthesis in Women Undergoing Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry) 39
Clinical and Procedural Outcomes of 5-French versus 6-French Sheaths in Transradial Coronary Interventions 39
Rationale for Early Administration of PCSK9 Inhibitors in Acute Coronary Syndrome 38
Acute Kidney Injury After Transcatheter Aortic Valve Replacement Mediates the Effect of Chronic Kidney Disease 38
Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO‐3 randomized trial 37
Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta‐analysis 37
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction 37
Exosomal microRNAs in heart disease 37
Reliability of Instantaneous Wave-Free Ratio (iFR) for the Evaluation of Left Main Coronary Artery Lesions 36
Simultaneous Radial and Ipsilateral Ulnar Artery Compression versus Isolated Radial Artery Compression after Conventional Radial Access for Coronary Angiography and/or Intervention: A Systematic Review and Meta-Analysis 36
Unmet Needs in TAVR: Conduction Disturbances and Management of Coronary Artery Disease 35
Effect of SGLT2 inhibitors on cardiac structure and function assessed by cardiac magnetic resonance: a systematic review and meta-analysis 35
The prevalence, predictors and outcomes of guideline‐directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry 34
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age 34
Effect of Transcatheter Aortic Valve Implantation on Non-Invasive Myocardial Work Parameters: A Systematic Review and Meta-Analysis 34
Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents 34
The link between anemia and adverse outcomes in patients with acute coronary syndrome 33
Cerebral Embolic Protection During TAVR 33
Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence 33
Assessing and minimizing the risk of percutaneous coronary intervention in patients with chronic kidney disease 33
Bioprosthetic leaflet thrombosis and reduced leaflet motion after transcatheter aortic valve replacement: A systematic review and meta-analysis 33
Artificial Intelligence in Cardiac Electrophysiology: A Clinically Oriented Review with Engineering Primers 32
Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention—Results from the PROMETHEUS registry 32
Stent Thrombosis After Percutaneous Coronary Intervention: From Bare-Metal to the Last Generation of Drug-Eluting Stents 32
Impact of Baseline Atrial Fibrillation on Outcomes Among Women Who Underwent Contemporary Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry) 31
The Telecardiology Revolution: From Emergency Management to Daily Clinical Practice 31
Standard Versus Ultrasound-Guided Cannulation of the Femoral Artery in Patients Undergoing Invasive Procedures: A Meta-Analysis of Randomized Controlled Trials 31
Common Calcified Femoral Artery Rupture After Intravascular Lithotripsy for TAVR Implantation 31
Stent Thrombosis After Percutaneous Coronary Intervention 30
Reduction of hospitalisations and increased mortality for acute coronary syndromes during covid-19 era: Not all countries are equal 30
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention 30
Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention 30
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry) 29
Impact of pre‐existing or new‐onset atrial fibrillation on 30‐day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial 28
Feasibility of measuring patient-reported health status at time of percutaneous coronary intervention: Results from a single-center quality-improvement initiative 26
Temporal trends, determinants, and impact of high-intensity statin prescriptions after percutaneous coronary intervention 26
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 26
Clinical manifestations and outcomes of coronavirus disease‐19 in heart transplant recipients: a multicentre case series with a systematic review and meta‐analysis 24
Sex‐Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient‐Level Pooled Analysis From 4 Postapproval Studies 24
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies 24
Vascular Complications in Patients Undergoing Transcatheter Aortic Valve Replacement With Contemporary Devices 23
Limitations of Current Risk Scoring in Real World Populations: The Importance of External Validation 22
Drug-coated balloons and hybrid strategies versus drug-eluting stents in chronic total occlusions: a systematic review and meta-analysis 22
Early safety after TAVR according to VARC-3 criteria: incidence, predictors, and clinical impact 22
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry 21
Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions 21
Totale 4.460
Categoria #
all - tutte 39.165
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.165


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022121 0 0 3 29 11 4 0 28 12 13 18 3
2022/2023370 80 12 40 13 48 29 3 27 57 21 31 9
2023/2024236 29 23 12 12 3 43 0 13 64 5 18 14
2024/2025848 102 35 35 23 60 138 43 16 82 17 117 180
2025/20262.706 100 243 162 288 300 108 316 136 337 221 318 177
2026/2027301 33 141 127 0 0 0 0 0 0 0 0 0
Totale 4.695